Pseudomonas aeruginosa compared with Escherichia coli produces less endotoxemia but more cardiovascular dysfunction and mortality in a canine model of septic shock
- PMID: 2245691
- DOI: 10.1378/chest.98.6.1480
Pseudomonas aeruginosa compared with Escherichia coli produces less endotoxemia but more cardiovascular dysfunction and mortality in a canine model of septic shock
Abstract
We investigated the effects of two different Gram-negative bacteria and radiation-induced leukopenia on endotoxemia, cardiovascular abnormalities, and mortality in a canine model of septic shock. Serial hemodynamics were measured in conscious dogs using radionuclide heart scans and thermodilution cardiac output catheters. Plasma endotoxin concentrations were determined with a chromogenic Limulus amebocyte lysate assay. Viable Pseudomonas aeruginosa or Escherichia coli implanted intraperitoneally produced concordant hemodynamic patterns of septic shock (p less than 0.01). Endotoxin concentrations were more than tenfold lower in dogs infected with P aeruginosa compared with E coli (p less than 0.0001). Despite lower endotoxin levels, P aeruginosa-infected dogs had a higher mortality (p less than 0.01), more severe hypotension (p less than 0.05), and greater depression of the left ventricular ejection fraction (p less than 0.05) than dogs with E coli sepsis. A nonlethal E coli challenge combined with leukopenia (induced by a nonlethal dose of radiation) resulted in a mortality of 60 percent (p less than 0.01) without greater cardiovascular dysfunction or higher endotoxin concentrations. These findings suggest that bacterial products other than endotoxin and host-related factors may be important contributors to the toxicity, cardiovascular instability, and mortality of Gram-negative septic shock. Quantitative determinations of plasma endotoxin are unlikely to correlate with the clinical severity of septicemia in heterogeneous patient populations infected with different Gram-negative organisms.
Similar articles
-
Role of endotoxemia in cardiovascular dysfunction and lethality: virulent and nonvirulent Escherichia coli challenges in a canine model of septic shock.Infect Immun. 1996 Feb;64(2):406-12. doi: 10.1128/iai.64.2.406-412.1996. Infect Immun. 1996. PMID: 8550184 Free PMC article.
-
Role of endotoxemia in cardiovascular dysfunction and mortality. Escherichia coli and Staphylococcus aureus challenges in a canine model of human septic shock.J Clin Invest. 1989 Jan;83(1):243-51. doi: 10.1172/JCI113866. J Clin Invest. 1989. PMID: 2642920 Free PMC article.
-
Endotoxin and tumor necrosis factor challenges in dogs simulate the cardiovascular profile of human septic shock.J Exp Med. 1989 Mar 1;169(3):823-32. doi: 10.1084/jem.169.3.823. J Exp Med. 1989. PMID: 2647895 Free PMC article.
-
Heart failure in septic shock: effects of inotropic support.Crit Care Med. 1990 Jan;18(1 Pt 2):S49-55. Crit Care Med. 1990. PMID: 2403514 Review.
-
Systemic hemodynamic abnormalities and vasopressor therapy in sepsis and septic shock.Am J Kidney Dis. 1992 Sep;20(3):214-22. doi: 10.1016/s0272-6386(12)80693-7. Am J Kidney Dis. 1992. PMID: 1519602 Review.
Cited by
-
Supplemental immunoglobulin (ivIgG) treatment in 163 patients with sepsis and septic shock--an observational study as a prerequisite for placebo-controlled clinical trials.Infection. 1991 Jul-Aug;19(4):216-27. doi: 10.1007/BF01644948. Infection. 1991. PMID: 1917032 Clinical Trial.
-
Alpha-2-macroglobulin as the major defence in acute pseudomonal septic shock in the guinea-pig model.Int J Exp Pathol. 1994 Aug;75(4):285-93. Int J Exp Pathol. 1994. PMID: 7524612 Free PMC article.
-
Role of endotoxemia in cardiovascular dysfunction and lethality: virulent and nonvirulent Escherichia coli challenges in a canine model of septic shock.Infect Immun. 1996 Feb;64(2):406-12. doi: 10.1128/iai.64.2.406-412.1996. Infect Immun. 1996. PMID: 8550184 Free PMC article.
-
Mechanisms in acute septic cardiomyopathy: evidence from isolated myocytes.Basic Res Cardiol. 1991 Sep-Oct;86(5):411-21. doi: 10.1007/BF02190709. Basic Res Cardiol. 1991. PMID: 1662946 Review.
-
N omega-amino-L-arginine, an inhibitor of nitric oxide synthase, raises vascular resistance but increases mortality rates in awake canines challenged with endotoxin.J Exp Med. 1992 Oct 1;176(4):1175-82. doi: 10.1084/jem.176.4.1175. J Exp Med. 1992. PMID: 1383377 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical